Browse studies

Find your next paid study

27,292 recruiting studies available now

A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate Efficacy, Safety, and Tolerability of HM15275 for 36 Weeks in Subjects With Type 2 Diabetes Mellitus

This study is a Phase 2 clinical trial to evaluate the efficacy, safety, and tolerability of HM15275 in subjects with type 2 diabetes mellitus over 36 weeks.

Type 2 Diabetes MellitusT2DM

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Hanmi Pharmaceutical Company LimitedNCT07527650

Phase 1

A Phase 1 Study of VX-581 in Healthy Subjects and in Subjects With Cystic Fibrosis

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of single dose of VX-581 and multiple ascending doses of VX-581 alone a…

Cystic Fibrosis

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Vertex Pharmaceuticals IncorporatedNCT07283770

Observational

The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial

The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy (STICH3C) trial is a prospective, unblinded, international multi-center randomized trial of 7…

Coronary Artery DiseaseHeart Failure Systolic

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Sunnybrook Health Sciences CentreNCT05427370

Aveir AR Coverage With Evidence Development (CED) Study

The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the single-chamber Aveir Atria…

Cardiac PacemakerArrhythmiaBradycardia

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Abbott Medical DevicesNCT06100770

Phase 3

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Cessation Interventions

This phase III trial compares the effect of text-based cessation intervention to a manual in helping rural cancer patients who smoke, quit. Text-based schedule…

Cigarette Smoking-Related Carcinoma

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Alliance for Clinical Trials in OncologyNCT05008848

Observational

A Randomized, Double-blind, Parallel-arm, Sham-controlled Trial of ElectraRx Mindfulness Transcranial Direct Current Treatment System (Elect-MDS) for Adults With Major Depressive Disorder

This study will test the efficacy of transcranial direct current stimulation (tDCS) combined with mindfulness, remotely-delivered using a telemedicine protocol…

Unipolar Depression

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Soterix MedicalNCT07042217

Observational

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

The objective of this study is to assess the safety and efficacy of Apreo BREATHE system when used to support native airways and release trapped air in the tre…

COPDEmphysema

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Apreo Health, Inc.NCT06891755

Phase 2

Dynamic Assessments of Molecular Response to Guide Early 177Lu-PSMA-617 Treatment Discontinuation: The DYNAMO Study

This clinical trial studies whether measuring circulating tumor deoxyribonucleic acid (ctDNA) tumor fraction (TF) can be used to help guide the early stopping …

Metastatic Castration-Resistant Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of WashingtonNCT07698535

Characteristics And Clinical Course Of Disease In Participants With Cardiomyopathy Associated With Friedreich Ataxia (CLARITY-FA)

Characteristics and clinical course of disease In participants with cardiomyopathy associated with Friedreich Ataxia (CLARITY-FA)

Friedreich AtaxiaCardiomyopathy

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Lexeo TherapeuticsNCT06865482

Phase 3

A Phase 3, Multicenter, Prospective Open-Label Study of the Diagnostic Performance of [¹⁸F]FAPI-74 PET/CT for the Detection of Metastatic Disease in Adults With Gastric or Esophageal Cancer

This is a multi-site, open-label, non-randomized, single dose study to assess the clinical utility of \[¹⁸F\]FAPI-74 PET/CT in the detection of metastatic dise…

Esophageal CancerGastric Cancer (GC)Gastroesophageal Junction

Estimated

~$50 – $2,250

Actual pay is set by the research site.

SOFIENCT07217704

An Ambispective Safety and Effectiveness Evaluation of OsteoFlo HydroFiber

The goal of this observational, ambispective study is to collect real world patient outcomes to characterize the safety and effectiveness of OsteoFlo HydroFibe…

OsteoFlo HydroFiber

Estimated

~$10 – $1,050

Actual pay is set by the research site.

SurGenTec LLCNCT07784673

Phase 3

An Interventional, Open-Label, Randomized, Multicenter, Phase 3 Study of PF-07248144 Plus Fulvestrant Compared to Investigator's Choice of Therapy in Adult Participants With Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Cancer Whose Disease Progressed After Prior CDK4/6 Inhibitor-based Therapy

The purpose of this study is to learn about the safety and effects of the study medicine PF-07248144 when given along with fulvestrant for the possible treatme…

Breast Cancer

Estimated

~$50 – $2,250

Actual pay is set by the research site.

PfizerNCT07062965